The phrase "a weak performer" is correct and usable in written English.
It can be used to describe someone or something that does not meet expected standards or levels of performance in a particular context, such as in a workplace or academic setting.
Example: "In the recent evaluation, Sarah was identified as a weak performer compared to her peers, prompting a discussion about additional support and training."
Alternatives: "underperformer" or "poor performer".
Much can be said about each act — there's not a weak performer in the bunch — but some mention should be made of the show's friendliness and intimacy.
A winter campaign has put more emphasis on television, a medium in which Mr Bersani is a weak performer and Mr Berlusconi a powerful proprietor; his Mediaset group still has a near-monopoly on private TV.
Even the best trusts are finding the current climate tough, and the spectre of Heart of England foundation trust's troubled takeover of Good Hope hospital remains a powerful warning of the difficulties of taking on a weak performer.
Citigroup's stock has been a weak performer during Mr. Prince's reign and the resulting low valuation has made all the harder for the bank to make the acquisitions that were Mr. Weill's trademark and that analysts say are necessary to keep the bank growing at an acceptable pace.
Back in the late 1960's, when the show was a sensation at the Village Gate in Greenwich Village, a weak performer or an off night might have been overcome by the sheer audacity of the production -- no plot, virtually no dialogue or props; just two male and two female singer/actors, left to draw character and cohesion out of Brel's wonderful melodies.
Legacy's market capitalization is $485 million, and it has been a weak performer.
Arby's has been a weaker performer than Wendy's in recent years.
Selection that favors top performers disproportionately to intermediate performers could hypothetically transform a weak performance trade-off into a strong fitness trade-off.
GLOBAL oil production posted its biggest increase since 2004 last year but it was a relatively weak performer in a bumper year for energy growth, according to BP's latest annual Statistical Review of World Energy.
"He is nonetheless a problematic, weak performer; his basic posture is awkward (he seems unsure about how to carry his head or his jaw), his rhythm and attack seldom excite, and his stage persona is freakish and overwrought".
The patent expiration of top sellers like the antipsychotic Risperdal and controversies over the company's Procrit anemia drug have made J&J's giant pharma division a relatively weak performer.
